Amprius Technologies (NYSE:AMPX) Price Target Raised to $22.00 at B. Riley Financial

Amprius Technologies (NYSE:AMPX) had its target price raised by equities research analysts at B. Riley Financial from $16.00 to $22.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. B. Riley Financial’s target price indicates a potential upside of 31.58% from the stock’s previous close.

Other analysts also recently issued reports about the company. Cantor Fitzgerald lifted their price target on Amprius Technologies from $16.00 to $20.00 and gave the company an “overweight” rating in a research note on Friday. William Blair restated an “outperform” rating on shares of Amprius Technologies in a research report on Friday. Oppenheimer reaffirmed an “outperform” rating and set a $17.00 price target on shares of Amprius Technologies in a research note on Tuesday, December 23rd. Roth Mkm reiterated a “buy” rating and issued a $20.00 price target (up from $16.00) on shares of Amprius Technologies in a report on Friday. Finally, Craig Hallum raised their price objective on shares of Amprius Technologies from $17.00 to $21.00 and gave the company a “buy” rating in a research note on Friday. Eight investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $19.75.

Amprius Technologies Trading Up 2.4%

Shares of NYSE:AMPX traded up $0.39 during midday trading on Monday, hitting $16.72. The stock had a trading volume of 4,681,237 shares, compared to its average volume of 8,843,817. Amprius Technologies has a 1 year low of $1.70 and a 1 year high of $17.29. The stock has a 50 day moving average price of $10.88 and a two-hundred day moving average price of $10.75. The company has a market capitalization of $2.18 billion, a PE ratio of -49.18 and a beta of 3.04.

Amprius Technologies (NYSE:AMPX) last announced its quarterly earnings data on Wednesday, March 4th. The company reported ($0.01) EPS for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.03. Amprius Technologies had a negative net margin of 60.30% and a negative return on equity of 25.77%. The firm had revenue of $25.23 million during the quarter, compared to the consensus estimate of $22.91 million. Amprius Technologies has set its FY 2026 guidance at –0.060 EPS. As a group, equities analysts expect that Amprius Technologies will post -0.45 EPS for the current year.

Insider Buying and Selling at Amprius Technologies

In related news, CTO Constantin Ionel Stefan sold 25,366 shares of the stock in a transaction dated Monday, February 23rd. The shares were sold at an average price of $10.16, for a total value of $257,718.56. Following the sale, the chief technology officer directly owned 723,330 shares of the company’s stock, valued at approximately $7,349,032.80. This represents a 3.39% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Kang Sun sold 61,251 shares of the firm’s stock in a transaction dated Monday, February 23rd. The shares were sold at an average price of $10.16, for a total transaction of $622,310.16. Following the transaction, the director owned 1,342,400 shares of the company’s stock, valued at $13,638,784. This trade represents a 4.36% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 2,392,269 shares of company stock worth $26,384,359 in the last three months. 12.90% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Bank of America Corp DE lifted its stake in Amprius Technologies by 31.1% in the 4th quarter. Bank of America Corp DE now owns 12,890 shares of the company’s stock valued at $36,000 after buying an additional 3,055 shares in the last quarter. AQR Capital Management LLC increased its position in Amprius Technologies by 86.7% during the first quarter. AQR Capital Management LLC now owns 77,764 shares of the company’s stock worth $208,000 after buying an additional 36,116 shares in the last quarter. Millennium Management LLC lifted its position in shares of Amprius Technologies by 94.5% in the first quarter. Millennium Management LLC now owns 1,396,013 shares of the company’s stock valued at $3,741,000 after acquiring an additional 678,442 shares in the last quarter. Goldman Sachs Group Inc. lifted its position in shares of Amprius Technologies by 128.6% in the first quarter. Goldman Sachs Group Inc. now owns 244,646 shares of the company’s stock valued at $656,000 after acquiring an additional 137,640 shares in the last quarter. Finally, Rhumbline Advisers boosted its stake in shares of Amprius Technologies by 61.1% during the first quarter. Rhumbline Advisers now owns 15,690 shares of the company’s stock valued at $42,000 after acquiring an additional 5,951 shares during the last quarter. 5.04% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting Amprius Technologies

Here are the key news stories impacting Amprius Technologies this week:

• Positive Sentiment: Q4 results showed record revenue growth and Amprius reported its first positive quarterly adjusted EBITDA, driven by broader adoption of its 2nd‑generation silicon‑anode batteries and new commercial wins (including Nokia Drone Networks). Management also said progress toward NDAA compliance is ahead of schedule — important for future U.S. government business. Amprius Revenue Milestone And EBITDA Turn As Battery Adoption Broadens
• Positive Sentiment: Amprius won a meaningful government contract (reported ~$14.8M with the Defense Innovation Unit) and is accelerating production consistent with NDAA sourcing requirements — this both validates product demand in defense markets and opens higher‑margin, repeatable revenue opportunities. Amprius Defense Contract Highlights NDAA Shift And Silicon Battery Adoption
• Positive Sentiment: Analysts have been upgrading coverage and raising price targets (several moves into the ~$20–$21 range), and firms have reiterated buys — a catalyst for fresh investor interest and higher volume. Craig‑Hallum, Cantor Fitzgerald and others increased targets and ratings over the past week. Amprius Technologies (NYSE:AMPX) Price Target Raised to $21.00
• Neutral Sentiment: Market/technical signals and heavy trading volume are validating the move — volume spiked around the earnings release and has supported the breakout, suggesting momentum could continue if fundamentals and news flow remain positive. How The Amprius Technologies (AMPX) Investment Story Is Shifting After New Targets And Guidance
• Negative Sentiment: Despite the upbeat developments, Amprius remains unprofitable on a GAAP basis (negative net margin/ROE) and consensus still expects negative EPS for the year; management set FY‑2026 guidance at roughly -$0.06 EPS and analysts model further loss for the current year — risks that could cap enthusiasm if growth slows or margins don’t improve.

Amprius Technologies Company Profile

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.